The Men had few options for contraception, but soon this can change thanks to the injection Vasalgel. This is added to the condom and the vasectomy.
The injection is placed near the testicles and is known as RISUG (Reverse Sperm Inhibition under Guidance) for its acronym in English, which means Reversible inhibition of spermatogenesis under guidance.
But its use is not so easy because the injection has to be done by a professional team and under local anaesthesia. The The application is near the genitals, but the procedure takes about 15 minutes.
The polymers are injected into the vas deferens, which are responsible for carrying sperm. At the end of the procedure, the gel remains firm and creates a plug in the ducts to prevent sperm from escaping.
The duration of the effect is about 13 years, but there is the possibility of interruption of its effects at any time decided by the patient. This is done by applying a solution that dissolves the gel so that the flow of sperm is regular again.
In December 2019 The Parsemus Foundation has asked the public to help through donations to help end the development of injections.
More than 85 million unplanned pregnancies occur worldwide each year; Half end in abortion. Men who are not dependent on their partners for contraception have few options: condoms, vasectomy, abstinence, or abstinence. We are developing a new option: Vasalgel, he said in a statement.
The company stated that its mission is to provide men with the first effective, long-term, and reversible option for controlling their fertility.
“We hope you will share our belief that Vasalgel will benefit millions of people around the world. Please donate to support the development of Vasalgel.
Its distribution plans were for last year, but the pandemic delayed its arrival. At the moment, it is not known when it will be available in Mexico, but it has been announced that the testing phase has ended, so its distribution could be closer and closer. Some estimates estimate it could cost as much as $150.
In November 2019, the Indian Council of Medical Research (ICMR) announced that it is ready to revolutionize reproductive health in the world.
Hindustan Times newspaper It revealed that ICMR, the main body dedicated to biomedical research in that country, announced that Successfully completed clinical trials of the world’s first injectable contraceptive, targeting sexually active men.
ICMR shall present to the health authorities of the countries in which it intends to commercialize the new contraceptives, the expanded phase III clinical tests that have been applied in 303 candidates, the methodology of the tests performed and the results obtained, among which:Success rate of 97.3% with no reported side effects“.
Dr. Anoop Kumar, Head of Urology and Kidney Transplant Department at Safdarjung Hospital, considered that it is possible that injectable contraceptives will surpass vasectomy in popularity.
“Non-surgical procedures are always preferred because they are safer and less invasive. More men are likely to choose them.